Articles:

1. D’Arrigo, J.S. (1973). Possible screening of surface charges on crayfish axons by polyvalent metal ions. J. Physiol. 231:117-128.

2. Eyring, H., J.W. Woodbury, & J.S. D’Arrigo. (1973). A molecular mechanism of general anesthesia. Anesthesiology 38:415-424.

3. D’Arrigo, J.S. (1974). Axonal surface charges: Binding or sceening by divalent cations governed by external pH. J. Physiol. 243:757-764.

4. D’Arrigo, J.S. (1975). Axonal surface charges: Evidence for phosphate structure. J. Membrane Biol. 22:255-263.

5. Woodbury, J.W., J.S. D’Arrigo, & H. Eyring. (1975). Molecular mechanism of general anesthesia: Lipoprotein conformation change theory. In: Progress in Anesthesiology, Vol. 1, Molecular Mechanisms of Anesthesia, ed. by B.R. Fink, pp.253-275. Raven Press, New York.

6. Woodbury, J.W., J.S. D’Arrigo, & H. Eyring. (1975). Physiological mechanism of general anesthesia: Synaptic blockade. In: Progress in Anesthesiology, Vol. 1, Molecular Mechanisms of Anesthesia, ed. by B.R. Fink, pp, 53-87. Raven Press, New York.

7. D’Arrigo, J.S. (1976). Structural characteristics of the saxitoxin receptor on nerve. J. Membrane Biol. 29:231-242.

8. D’Arrigo, J.S. (1977). Dissolved carbon dioxide: Evidence for a significant role in the etiology of decompression sickness. In: Proceedings of the Fourth Joint Meeting of the Panel on Diving Physiology and Technology, U.S.-Japan Cooperative Program in Natural Resources (UJNR), ed. by J.W. Miller, pp.88-100. Buffalo, New York.

9. Yount, D.E., T.D. Kunkle, J.S. D’Arrigo, F.W. Ingle, C. Yeung, & E.L. Beckman. (1977). Stabilization of gas cavitation nuclei by surface-active compounds. Aviation, Space & Environ. Med. 48:185-191.

10. Rayner, M.D., J.S. D’Arrigo, & L.L. Conquest. (1977). The gating currents of sodium channels: Pore-population-size effects. J. Supramol. Struc. 5:453-456, and Progress in Clinical and Biological Research, Vol. 15, Cellular Neurobiology, ed. by Z. Hall, R. Kelly, & C.F. Fox, pp.57-60. Alan R. Liss, Inc., New York (1977).

11. Guillory, R.J., M.D. Rayner, & J.S. D’Arrigo. (1977). Covalent labeling of the tetrodotoxin receptor in excitable membranes. Science 196:883-884.

12. D’Arrigo, J.S. (1978). Screening of membrane surface charges by divalent cations: An atomic representation. Amer. J. Physiol. 235:C109-C117.

13. D’Arrigo, J.S. (1978). An atomic model for ionic screening at charged membrane surfaces. In: Biomolecular Structure and Function, ed. by P.F. Agris, pp.151-158. Academic Press, New York.

14. D’Arrigo, J.S. (1978). Improved method for studying the surface chemistry of bubble formation. Aviation, Space & Environ. Med. 49:358-361.

15. Mano, Y., & J.S. D’Arrigo. (1978). The relationship between CO2 levels and decompession sickness: Implications for disease prevention. Aviation, Space & Environ. Med. 49:349-355.

16. D’Arrigo, J.S. (1979). Physical properties of nonionic surfactants surrounding gas cavitation nuclei. J. Chemical Physics 71:1809-1813.

17. D’Arrigo, J.S., & Y. Mano. (1979). Bubble production in agarose gels subjected to different decompression schedules. Undersea Biomed. Res. 6:93-98.

18. D’Arrigo, J.S. (1980). Structural features of the nonionic surfactants stabilizing long-lived bubble nuclei. J. Chemical Physics 72:5133-5138.

19. D’Arrigo, J.S., & B. Chanfour. (1980). Modulation of veratridine action on crustacean nerve by different divalent cations. Toxicon 18:395-398.

20. D’Arrigo, J.S. (1981). Strontium ions and membranes: Screening versus binding at charged surfaces. In: Handbook of Stable Strontium, ed. by S.C. Skoryna, pp. 167-182. Plenum Press, New York.

21. D’Arrigo, J.S. (1981). Aromatic proteinaceous surfactants stabilize long-lived gas microbubbles from natural sources. J. Chemical Physics 75:962-968.

22. D'Arrigo, J.S. (1982). Glycoprotein surfactants stabilize long-lived gas microbubbles in the environment. In: Microbial-Enhanced Oil Recovery, ed. by J.E. Zajic, pp. 124-140. PennWell Press, Tulsa.

23. D’Arrigo, J.S. (1983). Biological surfactants stabilizing natural microbubbles in aqueous media. Adv. Colloid & Interface Sci. 19:253-307.

24. D’Arrigo, J.S., C. Saiz-Jimenez, & N.S. Reimer. (1984). Geochemical properties and biochemical composition of the surfactant mixture surrounding natural microbubbles. J. Colloid & Interface Sci. 100:96-105.

25. D’Arrigo, J.S. (1984). Surface properties of microbubble-surfactant monolayers at the air/water interface. J. Colloid & Interface Sci. 100:106-111.

26. Simon, R.H., S.Y. Ho, J.S. D’Arrigo, A. Wakefield, & S.G. Hamilton. (1990). Lipid-coated ultrastable microbubbles as a contrast agent in neurosonogaphy. Investigative Radiology 25:1300-1304.

27. D’Arrigo, J.S. (1991). Contrast-assisted tumor detection. Drug News & Perspectives 4:164-167.

28. D’Arrigo, J.S., R.H. Simon, & S.Y. Ho. (1991). Lipid-coated uniform microbubbles for earlier sonographic detection of brain tumors. J. Neuroimaging 1:134-139.

29. Simon, R.H., S.Y. Ho, C.R. Perkins, & J.S. D’Arrigo. (1992). A quantitative assessment of tumor enhancement by ultrastable lipid-coated microbubbles as a contrast agent. Investigative Radiology 27:29-34.

30. D’Arrigo, J.S., & T. Imae. (1992). Physical characteristics of ultrastable lipid-coated microbubbles. J. Colloid & Interface Sci. 149:592-595.

31. D’Arrigo, J.S., S.Y. Ho, & R.H. Simon. (1993). Detection of experimental rat liver tumors by contrast-assisted ultrasonography. Investigative Radiology 28:218-222.

32. Simon, R.H., S.Y. Ho, D.F. Uphoff, S.C. Lange, & J.S. D’Arrigo. (1993). Applications of lipid-coated microbubble ultrasonic contrast to tumor therapy. Ultrasound in Medicine & Biology 19:123-125.

33. Barbarese, E., S.Y. Ho, J.S. D'Arrigo, & R.H. Simon. (1995). Internalization of microbubbles by tumor cells in vivo and in vitro. J. Neuro-Oncology 26:25-34.

34. Ho, S.Y., X.G. Li, A. Wakefield, E. Barbarese, J.S. D'Arrigo, & R.H. Simon. (1997). The affinity of lipid-coated microbubbles for maturing brain injury sites. Brain Res. Bull. 43:543-549.

35. Ho, S.Y., E. Barbarese, J.S. D’Arrigo, C. Smith, & R.H. Simon. (1997). Evaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in tumor therapy. Neurosurgery 40:1260-1268.

36. Wakefield, A.F., S.Y. Ho, X.G. Li, J.S. D'Arrigo, & R.H. Simon. (1998). The use of lipid-coated microbubbles as a delivery agent for 7B-hydroxycholesterol to a radiofrequency lesion in the rat brain. Neurosurgery 42:592-598.

37. Kureshi, I.U., S.Y. Ho, H.C. Onyiuke, A.E. Wakefield, J.S. D'Arrigo, & R.H. Simon. (1999). The affinity of lipid-coated microbubbles to maturing spinal cord injury sites. Neurosurgery 44:1047-1053.

38. D'Arrigo, J.S. (2017). Alzheimer's disease, brain injury, and C.N.S. nanotherapy in humans: Sonoporation augmenting drug targeting. Medical Sciences 5(4):29; doi:10.3390/medsci5040029.

39. D'Arrigo, J.S. (2018). Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium. Adv. Colloid Interface Sci. 251:44-54.

40. D'Arrigo, J.S. (2018). Treating early dementia: Drug targeting and circumventing the blood-brain barrier. Geriatr. Med. Care 1(2):1-7; doi:10.15761/GMC.1000111.

41. D'Arrigo, J.S. (2018). Targeting early dementia: Using lipid cubic phase nanocarriers to cross the blood-brain barrier. Biomimetics 3(1):4.

42. D'Arrigo, J.S. (2019). Nanotherapy to delay cognitive impairment: Using colloidal nanocarriers to block amyloid-beta-induced damage in brain cell membranes. SDRP J. Nanotech. Mat. Sci. 2(1):94-105.

43. D'Arrigo, J.S. (2019). Treating dementia early: Limiting cellular damage in brain tissue. OBM Geriatrics 3(2):19.

44. D'Arrigo, J.S. (2019). Delaying dementia: Targeted brain delivery using lipid cubic phases. OBM Neurobiology 3(3), doi:10.21926/obm.neurobiol.1903040 .

45. D'Arrigo, J.S. (2020). Biomaterial to improve drug delivery in Alzheimer's disease: Linking major pathogenic pathways. OBM Geriatrics 4,(1):10.

46. D'Arrigo, J.S. (2020). Biomimetic nanocarrier targeting drug(s) to upstream-receptor mechanisms in dementia: Focusing on linking pathogenic cascades. Biomimetics 5(1):11.

47. D'Arrigo, J.S. (2020). Nanotargeting dementia etiology: Aiming drug nanocarriers toward receptors for vascular endothelium, serum amyloid A, inflammasomes, and oxidative stress. Nano Prog. 2(3):25-30.

48. D'Arrigo, J.S. (2020). Nanotargeting of drug(s) for delaying dementia: Relevance of Covid-19 impact on dementia. (Submitted for publication.)